Sort by
Refine Your Search
-
prevalent group (mutations in STXBP1), and to design intervention strategies. Our research is developed within the framework of a European consortium, ESCO, where scientists, clinicians, patient families and
-
treatment for each patient, greatly improving treatment outcomes worldwide. Therefore, in this PhD project, you will fundamentally change how quantitative MRI is obtained and develop innovative AI approaches
-
underlying inherited forms of SCD, with the aim of developing new therapeutic strategies. In this context, the role of cell types other than cardiomyocytes is becoming increasingly relevant, opening up
-
partner universities on the topic of translational research. Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page . As a doctoral